Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2902)
All Articles published online
|
Nov 14, 2005 (publication date) through Jan 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abbas Z, Moatter T, Hussainy A, Jafri W. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. World J Gastroenterol 2005; 11(42): 6656-6661 [PMID: 16425360 DOI: 10.3748/wjg.v11.i42.6656] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i42/6656.htm |
| Number | Citing Articles |
| 1 |
Glenda Nicioli da Silva, Maura Moscardi Bacchi, Cláudia Aparecida Rainho, Deilson Elgui de Oliveira. Epstein-Barr Virus Infection and Single Nucleotide Polymorphisms in the Promoter Region of Interleukin 10 Gene in Patients With Hodgkin Lymphoma. Archives of Pathology & Laboratory Medicine 2007; 131(11): 1691 doi: 10.5858/2007-131-1691-EVIASN
|
| 2 |
Juliana B. Oliveira, Paula C.V. Silva, Leticia M. Vasconcelos, Adriana V. Gomes, Maria Rosãngela C.D. Coêlho, Georgea G.O.M. Cahu, Maria Tereza Cartaxo Muniz, Ana Lúcia C. Domingues. Influence of Polymorphism (-G308A)TNF-αon the Periportal Fibrosis Regression of Schistosomiasis After Specific Treatment. Genetic Testing and Molecular Biomarkers 2015; 19(11): 598 doi: 10.1089/gtmb.2015.0091
|
| 3 |
Maryam Karkhane, Abdolrazagh Marzban, Hamed Esmaeil Lashgarian, Mohammad Reza Zali. Genetic Variations in Host Factors and their Critical Role on HCV Medication. Research in Molecular Medicine 2017; 5(1): 6 doi: 10.29252/rmm.5.1.6
|
| 4 |
Nadia Bouzgarrou, Elham Hassen, Olfa Bahri, Sallouha Gabbouj, Nabil Ben Mami, Henda Triki, Lotfi Chouchane. Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients. Hepatology International 2011; 5(2): 681 doi: 10.1007/s12072-010-9232-0
|
| 5 |
Dennis Eurich, Marcus Bahra, Sabine Boas-Knoop, Johan F. Lock, Jennifer Golembus, Ruth Neuhaus, Peter Neuhaus, Ulf P. Neumann. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease. Liver Transplantation 2011; 17(3): 279 doi: 10.1002/lt.22190
|
| 6 |
K Wang. Molecular mechanisms of hepatic apoptosis. Cell Death & Disease 2014; 5(1): e996 doi: 10.1038/cddis.2013.499
|
| 7 |
Sara Corchado, Mercedes Márquez, Montserrat Montes de Oca, Paula Romero-Cores, Clotilde Fernández-Gutiérrez, José-Antonio Girón-González, Sung Key Jang. Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients. PLoS ONE 2013; 8(6): e66619 doi: 10.1371/journal.pone.0066619
|
| 8 |
Ali Mandegary, Arastoo Saeedi, Aziz Eftekhari, Vahideh Montazeri, Elham Sharif. Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism. DARU Journal of Pharmaceutical Sciences 2013; 21(1) doi: 10.1186/2008-2231-21-28
|
| 9 |
Naylê Maria Oliveira da Silva, Fabiana Nunes Germano, Beatris Maria Vidales-Braz, Ricardo do Carmo Zanella, Deise Machado dos Santos, Rubens Lobato, Ana Maria Barral de Martinez. Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil. Cytokine 2015; 73(2): 253 doi: 10.1016/j.cyto.2014.12.022
|
| 10 |
Abeer Sheneef, Mamdouh M. Esmat, Asmaa N. Mohammad, Aida A. Mahmoud, Hoda M. Moghazy, Amal K. Noureldin. Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus–Related Liver Cirrhosis Risk. Journal of Interferon & Cytokine Research 2017; 37(4): 175 doi: 10.1089/jir.2016.0106
|
| 11 |
Wedad M. Abdelraheem, Noha A. Hassuna, Sahar M. Abuloyoun, Hend M. Abdel Ghany, Hazem A. Rizk, Sayed F Abdelwahab. Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin. Archives of Virology 2016; 161(9): 2473 doi: 10.1007/s00705-016-2948-y
|
| 12 |
Leila Ksiaa Cheikhrouhou, Imen Sfar, Hajer Aounallah-Skhiri, Houda Aouadi, Salwa Jendoubi-Ayed, Taieb Ben Abdallah, Khaled Ayed, Yousr Lakhoua-Gorgi. Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection. Hepatobiliary & Pancreatic Diseases International 2011; 10(3): 280 doi: 10.1016/S1499-3872(11)60047-7
|
| 13 |
Nermine Ahmed Bahgat, Manal Mohamed Kamal, Ashraf Omar Abdelaziz, Mohamed Ahmed Mohye, Hend Ibrahim Shousha, Mae Mohamed ahmed, Tamer Mahmoud Elbaz, Mohamed Mahmoud Nabil. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression. Asian Pacific Journal of Cancer Prevention 2015; 16(12): 5025 doi: 10.7314/APJCP.2015.16.12.5025
|
| 14 |
William Botelho de Brito, Maria Alice Freitas Queiroz, Ednelza da Silva Graça Amoras, Sandra Souza Lima, Simone Regina Souza da Silva Conde, Eduardo José Melo dos Santos, Izaura Maria Vieira Cayres-Vallinoto, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. The TGFB1 -509C/T polymorphism and elevated TGF-β1 levels are associated with chronic hepatitis C and cirrhosis. Immunobiology 2020; 225(5): 152002 doi: 10.1016/j.imbio.2020.152002
|
| 15 |
Julie R. Jonsson, David M. Purdie, Andrew D. Clouston, Elizabeth E. Powell. Recognition of Genetic Factors Influencing the Progression of Hepatitis C. Molecular Diagnosis & Therapy 2008; 12(4): 209 doi: 10.1007/BF03256286
|
| 16 |
Edmondo Falleti, Carlo Fabris, Pierluigi Toniutto, Elisabetta Fontanini, Annarosa Cussigh, Maja Caldato, Elisabetta Rossi, Davide Bitetto, Rosalba Minisini, Carlo Smirne, Mario Pirisi. Genetic Polymorphisms of Inflammatory Cytokines and Liver Fibrosis Progression Due To Recurrent Hepatitis C. Journal of Interferon & Cytokine Research 2007; 27(3): 239 doi: 10.1089/jir.2006.0062
|
| 17 |
Muhammad Sohail Afzal, Sadia Anjum, Najam us Sahar Sadaf Zaidi. Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-α Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population. Hepatitis Monthly 2013; 13(6) doi: 10.5812/hepatmon.10274
|
| 18 |
D. Vu, T. Shah, J. Ansari, P. Sakharkar, Q. Yasir, R. Naraghi, I. Hutchinson, D. Min. Interferon‐gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients. Transplant Infectious Disease 2014; 16(5): 724 doi: 10.1111/tid.12285
|
| 19 |
Manuel Romero-Gomez, Mohamed Eslam, Agustín Ruiz, Marta Maraver. Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment. Liver International 2011; 31(4): 443 doi: 10.1111/j.1478-3231.2011.02449.x
|
| 20 |
Olfat G Shaker, Nermin A H Sadik. Polymorphisms in interleukin‐10 and interleukin‐28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin‐therapy. Journal of Gastroenterology and Hepatology 2012; 27(12): 1842 doi: 10.1111/j.1440-1746.2012.07273.x
|
| 21 |
Reham M. Dawood, Mai A. El-Meguid, Ghada Maher Salum, Mostafa K. El Awady. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020; 40(10): 472 doi: 10.1089/jir.2020.0059
|
| 22 |
Fernanda Albuquerque Pereira, Naize Nara Pinheiro da Silva, Itatiana Ferreira Rodart, Theomira Mauadie Azevedo Carmo, Denise Carneiro Lemaire, Mitermayer Galvão Reis. Association of TGF‐β1 codon 25 (G915C) polymorphism with hepatitis C virus infection. Journal of Medical Virology 2008; 80(1): 58 doi: 10.1002/jmv.21011
|
| 23 |
Gaurav Dogra, Anita Chakravarti, Premashish Kar, Yogesh Kumar Chawla. Polymorphism of tumor necrosis factor–α and interleukin-10 gene promoter region in chronic hepatitis C virus patients and their effect on pegylated interferon–α therapy response. Human Immunology 2011; 72(10): 935 doi: 10.1016/j.humimm.2011.06.008
|
| 24 |
Guillermo Mazzolini, Jan-Peter Sowa, Ali Canbay. Cell death mechanisms in human chronic liver diseases: a far cry from clinical applicability. Clinical Science 2016; 130(23): 2121 doi: 10.1042/CS20160035
|
| 25 |
Sowmya Mekala, SubbaRao V. Tulimilli, Ramasatyaveni Geesala, Kanakaraju Manupati, Neha R. Dhoke, Amitava Das. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor β during hepatic injury activates hepatic stellate cells. Canadian Journal of Physiology and Pharmacology 2018; 96(8): 728 doi: 10.1139/cjpp-2017-0768
|
| 26 |
Roba M. Talaat, Shimaa Elsharnoby, Mohamed S. Abdelkhalek, Soha Z. El-Shenawy, Samir Elmasry. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes’ Polymorphism on Risk of Hepatitis C Virus–Related Liver Cirrhosis. Immunological Investigations 2022; 51(3): 688 doi: 10.1080/08820139.2020.1869251
|
| 27 |
K I Plakhova, M R Rakhmatulina, N V Frigo, A R Galimov, I A Volkov, E L Vasil'eva, K I Plakhova, M R Rakhmatulina, N V Frigo, A R Galimov, I A Volkov, Ye L Vasiliyeva. Immune and genetic mechanisms of infertility andreproductive function disorders associated with humanurogenital chlamydial infection. Vestnik dermatologii i venerologii 2010; 86(6): 39 doi: 10.25208/vdv778
|
| 28 |
Kewei Wang. Molecular mechanisms of liver injury: Apoptosis or necrosis. Experimental and Toxicologic Pathology 2014; 66(8): 351 doi: 10.1016/j.etp.2014.04.004
|
| 29 |
Ji-Sheng Jing, Zhuo-Qun Wang, Ying-Kui Jiang, Xin-Yun Zhang, Wei-Min Jiang. Association of cytokine gene polymorphisms with chronic hepatitis C virus genotype 1b infection in Chinese Han population. Medicine 2020; 99(38): e22362 doi: 10.1097/MD.0000000000022362
|
| 30 |
Hanaa M. El-Karaksy, Sahar A. Sharaf, Iman A. Mandour, Engy A. Mogahed, Normeen H. Rady, Fatma A. El- Mougy. Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection. Human Immunology 2016; 77(12): 1248 doi: 10.1016/j.humimm.2016.09.005
|
| 31 |
N. Bouzgarrou, E. Hassen, S. Gabbouj, E. Schvoerer, N. Ben Mami, H. Triki, L. Chouchane. Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients. Gastroentérologie Clinique et Biologique 2010; 34(4-5): 297 doi: 10.1016/j.gcb.2010.03.008
|
| 32 |
Xiaoli Zhang, Dalan Hu, Bei Zhu, Cuiyu Wang, Juan He, Jianqing Wu, Rong Bin Yu, Wei Hong Zhao. Tumor Necrosis Factor-α Promoter Gene Polymorphisms Are Not Associated with Hepatitis C Virus Infection in Chinese Hemodialysis Patients. Renal Failure 2011; 33(6): 593 doi: 10.3109/0886022X.2011.585265
|
| 33 |
Nazia Selzner, Limin Chen, Ivan Borozan, Aled Edwards, E. Jenny Heathcote, Ian McGilvray. Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients. Journal of Hepatology 2008; 48(5): 708 doi: 10.1016/j.jhep.2008.02.010
|
| 34 |
Jamal Sarvari, Afagh Moattari, Neda Pirbonyeh, Maryam Moini, Seyed Younes Hosseini. The Impact of IFN‐γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran. Journal of Clinical Laboratory Analysis 2016; 30(4): 301 doi: 10.1002/jcla.21855
|
| 35 |
Mahmoud Fathy Dondeti, Eman Anwar El-Maadawy, Roba Mohamed Talaat. Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World Journal of Gastroenterology 2016; 22(30): 6800-6816 doi: 10.3748/wjg.v22.i30.6800
|
| 36 |
Karin Neukam, Antonio Caruz, Antonio Rivero-Juárez, Pablo Barreiro, Dolores Merino, Luis M. Real, Rocío Herrero, Angela Camacho, Vicente Soriano, Federico A. Di Lello, Juan Macías, Antonio Rivero, Juan A. Pineda. Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection. AIDS 2013; 27(17): 2715 doi: 10.1097/01.aids.0000432459.36970.a9
|
| 37 |
Andréa Monteiro Tarragô, Allyson Guimarães da Costa, João Paulo Diniz Pimentel, Samara Tatielle Monteiro Gomes, Felipe Bonfim Freitas, Pritesh Lalwani, Ana Ruth S. de Araújo, Flamir da Silva Victória, Marilú Barbieri Victória, Antônio Carlos Rosário Vallinoto, Aya Sadahiro, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Adriana Malheiro. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients. Human Immunology 2014; 75(11): 1075 doi: 10.1016/j.humimm.2014.08.198
|
| 38 |
Derek J. Pappas, Jorge R. Oksenberg. Multiple sclerosis pharmacogenomics. Neurology 2010; 74(1_supplement_1) doi: 10.1212/WNL.0b013e3181c980fb
|
| 39 |
Sara Tatiana Moreira, Giovanni Faria Silva, Camila Fernanda Verdichio de Moraes, Rejane Maria Tomasini Grotto, Maria Inês de Moura Campos Pardini, Maria da Graça Bicalho, Ricardo Alberto Moliterno. Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C. Meta Gene 2016; 9: 90 doi: 10.1016/j.mgene.2016.04.003
|
| 40 |
Samaneh Sepahi, Alireza Pasdar, Mitra Ahadi, Sina Gerayli, Sina Rostami, Zahra Meshkat. Haplotype Analysis of Interleukin-10 Gene Promoter Polymorphisms in Chronic Hepatitis C Infection: A Case Control Study. Viral Immunology 2014; 27(8): 398 doi: 10.1089/vim.2014.0024
|
| 41 |
Bogna Świątek-Kościelna, Ewelina Kałużna, Ewa Strauss, Danuta Januszkiewicz-Lewandowska, Iwona Bereszyńska, Jacek Wysocki, Jolanta Rembowska, Dominika Barcińska, Dariusz Antosik, Iwona Mozer-Lisewska, Jerzy Nowak. Interleukin 10 gene single nucleotide polymorphisms in Polish patients with chronic hepatitis C: Analysis of association with severity of disease and treatment outcome. Human Immunology 2017; 78(2): 192 doi: 10.1016/j.humimm.2016.10.015
|
| 42 |
Rabab A. Mohamed, Mohamed A. ELfeki, Wael Fathy, Sally I. Mostafa, Rania E. Sheir. The genetic association of cytokine genes, single nucleotide polymorphisms, and the incidence of liver cirrhosis in chronic hepatitis C Egyptian patients. Comparative Clinical Pathology 2018; 27(1): 61 doi: 10.1007/s00580-017-2553-9
|
| 43 |
Nadia Bouzgarrou, Elham Hassen, Karim Farhat, Olfa Bahri, Sallouha Gabbouj, Nadia Maamouri, Nabil Ben Mami, Hammouda Saffar, Abdelhalim Trabelsi, Henda Triki, Lotfi Chouchane. Combined analysis of interferon-γ and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Human Immunology 2009; 70(4): 230 doi: 10.1016/j.humimm.2009.01.019
|
| 44 |
George V. Papatheodoridis, Dimitrios Paraskevis. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection. Liver International 2008; 28(6): 764 doi: 10.1111/j.1478-3231.2008.01800.x
|
| 45 |
Angélica Menezes Santiago, Ednelza da Silva Graça Amoras, Maria Alice Freitas Queiroz, Simone Regina Souza da Silva Conde, Izaura Maria Vieira Cayres-Vallinoto, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. TNFA -308G>A and IL10 -1082A>G polymorphisms seem to be predictive biomarkers of chronic HCV infection. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06835-9
|
| 46 |
Omaima M. Abbas, Mohamed H. Abdel‐Rahman, Nabil A. Omar, Hanaa M. Badran, Elamir M. Amir. Interleukin‐10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co‐infection. Liver International 2009; 29(9): 1422 doi: 10.1111/j.1478-3231.2009.02068.x
|
| 47 |
Don Vu, Prashant Sakharkar, Tariq Shah, Robert Naraghi, Qazi Yasir, Ian Hutchinson, David Min. Association of Interferon Gamma Gene Polymorphisms With BK Virus Infection Among Hispanic Renal Allograft Recipients. Transplantation 2014; 97(6): 660 doi: 10.1097/01.TP.0000438115.20198.89
|
| 48 |
Edmondo Falleti, Carlo Fabris, Pierluigi Toniutto, Elisabetta Fontanini, Annarosa Cussigh, Davide Bitetto, Ezio Fornasiere, Claudio Avellini, Rosalba Minisini, Mario Pirisi. TGF-β1 genotypes in cirrhosis: Relationship with the occurrence of liver cancer. Cytokine 2008; 44(2): 256 doi: 10.1016/j.cyto.2008.08.008
|
| 49 |
Aritra Biswas, Nabyendu Gupta, Debanjali Gupta, Abira Datta, Rushna Firdaus, Prosanto Chowdhury, Maitreyee Bhattacharyya, Provash C. Sadhukhan. Association of TNF-alpha (−308 A/G) and IFN-gamma (+874 A/T) gene polymorphisms in response to spontaneous and treatment induced viral clearance in HCV infected multitransfused thalassemic patients. Cytokine 2018; 106: 148 doi: 10.1016/j.cyto.2017.10.026
|
| 50 |
Peng-Fei Guo, Juan Jin, Xiangru Sun. Influence of IL10 gene polymorphisms on the severity of liver fibrosis and susceptibility to liver cirrhosis in HBV/HCV-infected patients. Infection, Genetics and Evolution 2015; 30: 89 doi: 10.1016/j.meegid.2014.12.011
|
| 51 |
Francesc Vidal, Miguel López-Dupla, Montserrat Laguno, Sergi Veloso, Josep Mallolas, Javier Murillas, Carmen Cifuentes, Lluis Gallart, Teresa Auguet, Gloria Sampériz, Antoni Payeras, Pilar Hernandez, Mireia Arnedo, Josep Ma Gatell, Cristóbal Richart, Weijing He. Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants. PLoS ONE 2012; 7(11): e47725 doi: 10.1371/journal.pone.0047725
|
| 52 |
Nazia Selzner, Ian McGilvray. Can genetic variations predict HCV treatment outcomes?. Journal of Hepatology 2008; 49(4): 494 doi: 10.1016/j.jhep.2008.07.006
|
| 53 |
Jamal Sarvari, Hossin Norozian, Mohamad Reza Fattahi, Neda Pirbonyeh, Afagh Moattari. The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran. Hepatitis Monthly 2014; 14(1) doi: 10.5812/hepatmon.14476
|
| 54 |
Branwen J. Hennig, Angela J. Frodsham, Simon Hellier, Susanne Knapp, Leland J. Yee, Mark Wright, Lyna Zhang, Howard C. Thomas, Mark Thursz, Adrian V. Hill. Influence of IL‐10RA and IL‐22 polymorphisms on outcome of hepatitis C virus infection. Liver International 2007; 27(8): 1134 doi: 10.1111/j.1478-3231.2007.01518.x
|
| 55 |
Catherine O‘Doherty, Alexander Favorov, Shirley Heggarty, Colin Graham, Olga Favorova, Michael Ochs, Stanley Hawkins, Michael Hutchinson, Killian O‘Rourke, Koen Vandenbroeck. Genetic Polymorphisms, their Allele Combinations and IFN-β Treatment Response in Irish Multiple Sclerosis Patients. Pharmacogenomics 2009; 10(7): 1177 doi: 10.2217/pgs.09.41
|
| 56 |
Bogna J. Świątek. Is interleukin-10 gene polymorphism a predictive marker in HCV infection?. Cytokine & Growth Factor Reviews 2012; 23(1-2): 47 doi: 10.1016/j.cytogfr.2012.01.005
|
| 57 |
Adel Sepanjnia, Ebrahim Eskandari-Nasab, Mehdi Moghadampour, Arezoo Tahmasebi, Fatemeh Dahmardeh. TGFβ1genetic variants are associated with an increased risk of acute brucellosis. Infectious Diseases 2015; 47(7): 458 doi: 10.3109/23744235.2015.1016298
|
| 58 |
Muhammad Ali, Samia Afzal, Asad Zia, Ahmed Hassan, Ali Talha Khalil, Muhammad Ovais, Zabta Khan Shinwari, Muhammad Idrees. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges. Medicine 2016; 95(50): e5327 doi: 10.1097/MD.0000000000005327
|